New Marketplace

A Metrics Moonshot

Article · April 13, 2016

By the time I finished reading “Standardizing Patient Outcomes Measurement,” the New England Journal of Medicine article by Michael Porter, Tom Lee, and Stefan Larsson, I was cheering. The authors point out how a “let a thousand flowers bloom” approach to metrics development has resulted in a glut of process measures in health care and slowed progress toward metrics that reflect real outcomes. They decry the artisanal process by which organizations reinvent the metrics wheel over and over but with enough small differences to render broader comparisons of performance useless.

Our team at Weill Cornell Medicine recently compiled an inventory of the metrics by which we are measured by our four largest commercial payers and for our Medicare ACO. We counted 60 individual measures, with a grand total of 2 that apply across the entire group. All track processes rather than outcomes. There are similarities among the other 58 measures but also nuances that introduce a friction into our operations, to which we must devote significant resources to overcoming.

For example, 18% of the measures relate to management of patients who are diabetic. Every payer agrees on measuring the rate at which our attributed patients have an annual retinal eye exam. But while one payer simply measures whether an annual HbA1C level has been documented, another wants the level to be less than 9%. For one payer it is enough that we document prescribing a 180-day supply of a medication, where for another we need to demonstrate that the patient is taking that medication.

Is there is a business case for this complexity? Possibly, if you take the cynical viewpoint that the entities who administer payment for health care services want to set up providers to fail. I don’t believe that’s true — but the quantity of process measures is a real impediment in the quest for value in health care. Payers with a stated goal of improving quality are actively inhibiting progress toward more meaningful outcome measures.

If this patchwork quilt of process measures is the result of a focus on perfection — by specialty societies that choose measures they can control — then let me beg for imperfect uniformity instead. Variability has been linked to poorer outcomes in health care; surely we should apply the same lens to the metrics we use to measure those outcomes.

We’ve heard much recently about moonshots in medicine. This is a call for a metrics moonshot. The International Consortium for Health Outcomes Measurement, which seeks to identify and propagate well validated measures, is a great launching pad. But the planet on which health care needs to land is one where providers, payers and, most importantly, patients, define shared goals for health and measure efforts on how close we all are to achieving those goals. If all parties can devote the time and space to agree on the measures that matter, then health care’s complexity and cost will be reduced. Process measures are the pre-launch equipment checks that ensure our ship will function. Outcomes measures are what will make that giant step forward.

Meaningful outcomes measures will be out of reach as long as we expend our collective energies on reporting processes. Reducing the complexity of that reporting might just be the catalyst that practicing physicians need in order to focus on patient health.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.

Fee-for-Service Continues to Account for the Majority of Revenue

New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care

In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.

Sample Report Comparing Individual Patient-Reported Outcome Measures with FORCE-TJR National Norms

The Essential Role of Patient-Centered Registries in an Era of Electronic Health Records

Smartly designed patient-centered registries capture longitudinal data to augment EHRs and enhance quality improvement, policy, and research efforts.

Murray02_pullquote surgical care bundled payments accountable care organizations

Surgical Value — Beyond Bundled Payments

The surgeon has a crucial role in defining value for patients in a population — and not just when that patient is in need of the surgeon’s knife.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Value Based Care

194 Articles

A New Model for Pricing Drugs…

Are we paying too much for new drugs before we know how well they work?…

Prescription for an Ailing U.S. Health…

Three components for treating the unhealthy, uncompetitive U.S. health care market — beginning with a…

Prescription for an Ailing U.S. Health…

Three components for treating the unhealthy, uncompetitive U.S. health care market — beginning with a…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now